Clinical Trial Update: Psilocybin as a Treatment for Chronic Pain in Smokers [EARLY_Phase 1]

View source ↗

Summary

A Yale University-led early-phase trial is evaluating psilocybin as a treatment for chronic pain in smokers, with the study not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Yale University | Conditions: Smokers With Chronic Pain | EARLY_Phase 1 | Status: NOT_YET_RECRUITING